List of works - Grzegorz Helbig

A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients

scientific article

Acute Lymphoblastic Leukemia Transformation in Polycythemia Vera: A Rare Phenomenon

scientific article published on 24 March 2016

Acute myeloid leukemia in a 38-year-old hemodialyzed patient with von Hippel-Lindau disease

scientific article published on 22 August 2013

Advances in the diagnosis and treatment of eosinophilia

scientific article published on January 2014

Aggregates of pseudo-Gaucher cells after treatment of chronic myeloid leukemia in blastic phase

scientific article published on 08 November 2014

Allogeneic hematopoietic cell transplantation for multiple myeloma: A retrospective analysis of the Polish Myeloma Group

scientific article published on 09 September 2020

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin

scientific article published on 14 August 2019

Allogeneic transplantation for high-risk chronic lymphocytic leukemia-a summary of a 16-year experience

scientific article published on 27 March 2019

Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma

scientific article

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin

scientific article published in PLoS ONE

Autologous Hematopoietic Stem Cell Transplantation for High-risk Acute Lymphoblastic Leukemia: non-Randomized Study with a maximum Follow-up of more than 22 Years

scientific article published on July 2014

Autologous hematopoietic stem cell transplantation (AHSCT) for aggressive multiple sclerosis - whom, when and how.

scientific article

Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience

scientific article

Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis

scientific article published on 8 March 2013

Autologous stem cell transplantation for mantle cell lymphoma - single centre experience

scientific article published on 11 October 2013

Bing-Neel Syndrome with Detectable MYD88 L265P Gene Mutation as a Late Relapse Following Autologous Hematopoietic Stem Cell Transplantation for Waldenström's Macroglobulinemia

scientific article published in June 2017

Cardiovascular dysfunction as a common cause of mortality in hypereosinophilic syndromes

scientific article published on 22 July 2015

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

scientific article

Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome

scientific article published on 15 October 2013

Characteristics and clinical outcome of patients with hypereosinophilia of undetermined significance.

scientific article published on 14 December 2013

Chronic eosinophilic leukemia‐not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation ⬇️

scientific article published on March 31, 2012

Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors

article published in 2018

Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study.

scientific article published in June 2010

Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia - preliminary report

scientific article

Clinical significance of elastin turnover--focus on diseases affecting elastic fibres

scientific article

Coexistence of chronic lymphocytic leukemia and myeloproliferative neoplasm.

scientific article

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation

scientific article published on 01 May 2020

Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment.

scientific article

Diagnostic and therapeutic management in patients with hypereosinophilic syndromes

scientific article published on January 1, 2011

Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: retrospective study in 33 patients

scientific article published on 5 October 2012

Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia

scientific article published on 17 February 2011

Ear involvement in acute promyelocytic leukemia

scientific article published on 29 June 2017

Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)

scientific article published on 29 October 2019

Elastin metabolism is disrupted in patients after allogeneic hematopoietic stem cell transplantation (alloHSCT) for acute and chronic myeloid leukemia.

scientific article published on November 2008

Exquisite response to imatinib mesylate in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome: a 12-year experience of the Polish Hypereosinophilic Syndrome Study Group

scientific article published on 03 March 2020

Frequency of abnormal T-cells in hypereosinophilic syndrome and hypereosinophilia of undetermined significance- Extended follow-up

scientific article published on 4 June 2016

Fungal colonization of the respiratory tract in allogeneic and autologous hematopoietic stem cell transplant recipients: a study of 573 transplanted patients.

scientific article published on 24 April 2015

Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

article

Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT

scientific article published on 19 August 2019

Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome

scientific article published on January 2011

Heterogeneity among characteristics of hypereosinophilic syndromes

scientific article published on 14 April 2010

Idiopathic, asymptomatic, and durable blood hypereosinophilia-still many unknowns

scientific article published on 16 January 2014

Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript

scientific article published on 2 October 2015

Imatinib for the treatment of hypereosinophilic syndromes

scientific article

Imatinib mesylate for lymphocytic variant of hypereosinophilic syndrome ⬇️

scientific article published on December 16, 2011

Imatinib mesylate for unmutated hypereosinophilic syndromes: Does it work?

scientific article

Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome.

scientific article

Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT

scientific article published on 13 October 2008

Impact Of Spleen Size And Splenectomy On Outcomes Of Allogeneic Haematopoietic Cell Transplantation For Myelofibrosis: A Retrospective Analysis By The Chronic Malignancies Working Party On Behalf Of Ebmt

scientific article published on 16 October 2020

Induction therapy alters plasma fibrin clot properties in multiple myeloma patients: association with thromboembolic complications.

scientific article

Interferon alpha induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation

scientific article published on 01 November 2007

Irreversible marrow aplasia after single course of 2-chlorodeoxyadenosine for hairy cell leukaemia preceding by A pandemic 2009-H1N1-associated pneumonia

scientific article

Is it time for erythropoietin use in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients?

scientific article published on 01 December 2012

Kikuchi-Fujimoto and Kimura diseases: the selected, rare causes of neck lymphadenopathy

scientific article published on 16 October 2009

Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis.

scientific article published on 28 June 2017

Multiple tyrosine kinase inhibitors before allogeneic stem cell transplantation for chronic myeloid leukemia: toxicity and efficacy in a single center experience

scientific article published on 11 May 2020

Myeloid neoplasms with eosinophilia and FIP1L1-PDGFRA fusion gene: another point of view

scientific article

New drugs in multiple myeloma - role of carfilzomib and pomalidomide

scientific article published on 25 January 2014

Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience

scientific article

Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience

scientific article published on 30 September 2019

Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation

scientific article published on 24 April 2020

Preliminary results of monotherapy with thalidomide in recurrent and treatment resistant cases of multiple myeloma

scientific article published on January 1, 2003

Profile of serum biomarkers in eosinophilic disorders

scientific article published on 19 January 2016

Protective environment in hematopoietic cell transplantation centers: results of a survey of the Polish Federation of Bone Marrow Transplant Centers

scientific article published on 29 April 2021

Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies

scientific article published on 8 May 2007

Rapid reversal of quadraparesis in chronic eosinophilic leukaemia expressing the FIP1L1-PDGFRA transcript after therapy with imatinib.

scientific article published on 18 November 2010

Ras signaling pathway as a target for farnesyltransferase inhibitors--a new, promising prospects in the treatment for malignant disorders

scientific article

Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia

scientific article published on 06 January 2019

Resolution of thrombocytopenia, but not polycythemia after ruxolitinib for polycythemia vera with detectable mutation in the exon 12 of the JAK2 gene

scientific article published on 24 January 2017

Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation

scientific article published on 6 July 2012

Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis

scientific article

Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis

scientific article published on 02 September 2015

Safety and outcome of allogeneic stem cell transplantation in myelofibrosis.

scientific article

Safety profile of a single pegylated asparaginase (PEG-ASP) dose in remission induction for acute lymphoblastic leukemia (ALL)

scientific article published on 17 June 2018

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis.

scientific article published on 18 December 2017

Sarcoidosis with bone marrow involvement

scientific article published on 13 June 2014

Screening for JAK2 V617F point mutation in patients with hypereosinophilic syndrome-in response to 'Hypereosinophilic syndrome: another face of janus?' by Dahabreh et al. published in Leukemia Research, in press

scientific article published on 07 May 2008

Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis

scientific article published on 08 January 2019

Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.

scientific article published in November 2005

Sustained remission after ABVD treatment for interdigitating dendritic cell sarcoma

scientific article published on 4 July 2014

T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome

scientific article published on September 2009

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.

scientific article

The Efficacy of Cladribine (2-CdA) in Advanced Systemic Mastocytosis

scientific article published on 15 April 2020

The JAK2V617F tyrosine kinase mutation has no impact on overall survival and the risk of leukemic transformation in myelofibrosis ⬇️

scientific article published on March 1, 2012

The achievement of complete molecular remission after autologous stem cell transplantation for T-cell lymphoma with associated hypereosinophilia, rare aberration t(6;11) and elevated IL-4 and IgE

scientific article published on 01 August 2006

The efficacy and safety of autologous stem cell transplantation in relapsed chemosensitive and chemoresistant patients with diffuse large B-cell lymphoma

scientific article published on 24 July 2020

The kinetics of mRNA transforming growth factor beta1 expression and its serum concentration in graft-versus-host disease after allogeneic hemopoietic stem cell transplantation for myeloid leukemias

scientific article published on June 2011

The proportion of CD3- CD4+ T-cell population remained unaffected after corticosteroids treatment for lymphocytic variant hypereosinophilic syndrome (L-HES).

scientific article published on October 2010

The results of imatinib therapy for patients with primary eosinophilic disorders.

scientific article

The sudden onset of mastocytosis in the course of venom-induced anaphylactic reaction in a patient with myelodysplastic syndrome.

scientific article published in January 2015

Unexpected cause of anemia: metastasis of neuroendocrine tumor to the bone marrow.

scientific article

Very poor outcome of leukemic transformation in myelofibrosis: a single center experience with 13 patients

scientific article published on 3 January 2012

Weekly imatinib dosage for chronic eosinophilic leukaemia expressing FIP1L1-PDGFRA fusion transcript: extended follow-up

scientific article

[Oncogene Fip1-likeL/PDGFRalpha as a target for imatinib in patients with hypereosinophilic syndrome and chronic eosinophilic leukemia. A novel look at pathogenesis and therapy]

scientific article published on 01 May 2005

List of works by Grzegorz Helbig

A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients

Acute Lymphoblastic Leukemia Transformation in Polycythemia Vera: A Rare Phenomenon

Acute myeloid leukemia in a 38-year-old hemodialyzed patient with von Hippel-Lindau disease

Advances in the diagnosis and treatment of eosinophilia

Aggregates of pseudo-Gaucher cells after treatment of chronic myeloid leukemia in blastic phase

Allogeneic hematopoietic cell transplantation for multiple myeloma: A retrospective analysis of the Polish Myeloma Group

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin

Allogeneic transplantation for high-risk chronic lymphocytic leukemia-a summary of a 16-year experience

Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin

Autologous Hematopoietic Stem Cell Transplantation for High-risk Acute Lymphoblastic Leukemia: non-Randomized Study with a maximum Follow-up of more than 22 Years

Autologous hematopoietic stem cell transplantation (AHSCT) for aggressive multiple sclerosis - whom, when and how.

Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience

Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis

Autologous stem cell transplantation for mantle cell lymphoma - single centre experience

Bing-Neel Syndrome with Detectable MYD88 L265P Gene Mutation as a Late Relapse Following Autologous Hematopoietic Stem Cell Transplantation for Waldenström's Macroglobulinemia

Cardiovascular dysfunction as a common cause of mortality in hypereosinophilic syndromes

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome

Characteristics and clinical outcome of patients with hypereosinophilia of undetermined significance.

Chronic eosinophilic leukemia‐not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation ⬇️

Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors

Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study.

Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia - preliminary report

Clinical significance of elastin turnover--focus on diseases affecting elastic fibres

Coexistence of chronic lymphocytic leukemia and myeloproliferative neoplasm.

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation

Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment.

Diagnostic and therapeutic management in patients with hypereosinophilic syndromes

Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: retrospective study in 33 patients

Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia

Ear involvement in acute promyelocytic leukemia

Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)

Elastin metabolism is disrupted in patients after allogeneic hematopoietic stem cell transplantation (alloHSCT) for acute and chronic myeloid leukemia.

Exquisite response to imatinib mesylate in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome: a 12-year experience of the Polish Hypereosinophilic Syndrome Study Group

Frequency of abnormal T-cells in hypereosinophilic syndrome and hypereosinophilia of undetermined significance- Extended follow-up

Fungal colonization of the respiratory tract in allogeneic and autologous hematopoietic stem cell transplant recipients: a study of 573 transplanted patients.

Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT

Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome

Heterogeneity among characteristics of hypereosinophilic syndromes

Idiopathic, asymptomatic, and durable blood hypereosinophilia-still many unknowns

Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript

Imatinib for the treatment of hypereosinophilic syndromes

Imatinib mesylate for lymphocytic variant of hypereosinophilic syndrome ⬇️

Imatinib mesylate for unmutated hypereosinophilic syndromes: Does it work?

Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome.

Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT

Impact Of Spleen Size And Splenectomy On Outcomes Of Allogeneic Haematopoietic Cell Transplantation For Myelofibrosis: A Retrospective Analysis By The Chronic Malignancies Working Party On Behalf Of Ebmt

Induction therapy alters plasma fibrin clot properties in multiple myeloma patients: association with thromboembolic complications.

Interferon alpha induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation

Irreversible marrow aplasia after single course of 2-chlorodeoxyadenosine for hairy cell leukaemia preceding by A pandemic 2009-H1N1-associated pneumonia

Is it time for erythropoietin use in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients?

Kikuchi-Fujimoto and Kimura diseases: the selected, rare causes of neck lymphadenopathy

Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis.

Multiple tyrosine kinase inhibitors before allogeneic stem cell transplantation for chronic myeloid leukemia: toxicity and efficacy in a single center experience

Myeloid neoplasms with eosinophilia and FIP1L1-PDGFRA fusion gene: another point of view

New drugs in multiple myeloma - role of carfilzomib and pomalidomide

Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience

Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience

Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation

Preliminary results of monotherapy with thalidomide in recurrent and treatment resistant cases of multiple myeloma

Profile of serum biomarkers in eosinophilic disorders

Protective environment in hematopoietic cell transplantation centers: results of a survey of the Polish Federation of Bone Marrow Transplant Centers

Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies

Rapid reversal of quadraparesis in chronic eosinophilic leukaemia expressing the FIP1L1-PDGFRA transcript after therapy with imatinib.

Ras signaling pathway as a target for farnesyltransferase inhibitors--a new, promising prospects in the treatment for malignant disorders

Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia

Resolution of thrombocytopenia, but not polycythemia after ruxolitinib for polycythemia vera with detectable mutation in the exon 12 of the JAK2 gene

Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation

Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis

Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis

Safety and outcome of allogeneic stem cell transplantation in myelofibrosis.

Safety profile of a single pegylated asparaginase (PEG-ASP) dose in remission induction for acute lymphoblastic leukemia (ALL)

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis.

Sarcoidosis with bone marrow involvement

Screening for JAK2 V617F point mutation in patients with hypereosinophilic syndrome-in response to 'Hypereosinophilic syndrome: another face of janus?' by Dahabreh et al. published in Leukemia Research, in press

Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis

Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.